Disease diversity and FLT3 mutations

被引：5
|
作者：
Smith, Catherine Choy [1 ]
机构：
[1] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2013年 / 110卷 / 52期
关键词：
ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; GASTROINTESTINAL STROMAL TUMORS; KINASE DOMAIN MUTATIONS; THERAPEUTIC TARGET; ITD MUTATIONS; RESISTANCE; VALIDATION; ACTIVATION; GEFITINIB;
D O I：
10.1073/pnas.1320579110
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：20860 / 20861
页数：2
相关论文
共 50 条
  • [11] LT-171-861, a novel FLT3 inhibitor, shows excellent preclinical efficacy for the treatment of FLT3 mutant acute myeloid leukemia
    Yu, Zhou
    Du, Jiaying
    Hui, Hui
    Kan, Shaoxin
    Huo, Tongxin
    Zhao, Kai
    Wu, Tao
    Guo, Qinglong
    Lu, Na
    THERANOSTICS, 2021, 11 (01): : 93 - 106
  • [12] Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition
    Dzama, Margarita M.
    Steiner, Marlene
    Rausch, Johanna
    Sasca, Daniel
    Schoenfeld, Jonas
    Kunz, Kerstin
    Taubert, Martha C.
    McGeehan, Gerard M.
    Chen, Chun-Wei
    Mupo, Annalisa
    Haehnel, Patricia
    Theobald, Matthias
    Kindler, Thomas
    Koche, Richard P.
    Vassiliou, George S.
    Armstrong, Scott A.
    Kuehn, Michael W. M.
    BLOOD, 2020, 136 (21) : 2442 - 2456
  • [13] FLT3 Mutations in Myeloproliferative Neoplasms: The Beaumont Experience
    Williams, Lindsay
    Kelley, Harlan H.
    Meng, Xiuling
    Prada, Anne
    Crisan, Domnita
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2013, 22 (03) : 156 - 160
  • [14] Deciphering the molecular mechanism of FLT3 resistance mutations
    Georgoulia, Panagiota S.
    Bjelic, Sinisa
    Friedman, Ran
    FEBS JOURNAL, 2020, 287 (15) : 3200 - 3220
  • [15] FLT3 mutations in canine acute lymphocytic leukemia
    Suter, Steven E.
    Small, George W.
    Seiser, Eric L.
    Thomas, Rachael
    Breen, Matthew
    Richards, Kristy L.
    BMC CANCER, 2011, 11
  • [16] Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations
    Wang, Zhijie
    Cai, Jiongheng
    Ren, Jiwei
    Chen, Yun
    Wu, Yingli
    Cheng, Jie
    Jia, Kun
    Huang, Fei
    Cheng, Zitian
    Sheng, Tiancheng
    Song, Shiyu
    Heng, Hao
    Zhu, Yifan
    Tang, Weifang
    Li, Hongmei
    Lu, Tao
    Chen, Yadong
    Lu, Shuai
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (19) : 14664 - 14701
  • [17] Further activation of FLT3 mutants by FLT3 ligand
    Zheng, R.
    Bailey, E.
    Nguyen, B.
    Yang, X.
    Piloto, O.
    Levis, M.
    Small, D.
    ONCOGENE, 2011, 30 (38) : 4004 - 4014
  • [18] Distinct FLT3 Pathways Gene Expression Profiles in Pediatric De Novo Acute Lymphoblastic and Myeloid Leukemia with FLT3 Mutations: Implications for Targeted Therapy
    Zhao, Lizhen
    Chen, Hongbo
    Lan, Fengli
    Hao, Jinjin
    Zhang, Wenzhi
    Li, Ying
    Yin, Yuhong
    Huang, Minchun
    Wu, Xiaoyan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [19] FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia
    Daver, Naval
    Strati, Paolo
    Jabbour, Elias
    Kadia, Tapan
    Luthra, Raja
    Wang, Sa
    Patel, Keyur
    Ravandi, Farhad
    Cortes, Jorge
    Dong, Xiao Qin
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (01) : 56 - 59
  • [20] Frequency of FLT3 mutations in childhood acute lymphoblastic leukemia
    Braoudaki, M.
    Karpusas, M.
    Katsibardi, K.
    Papathanassiou, Ch.
    Karamolegou, K.
    Tzortzatou-Stathopoulou, F.
    MEDICAL ONCOLOGY, 2009, 26 (04) : 460 - 462
12345